ETHICA Trademark

Trademark Overview


On Tuesday, July 22, 2003, a trademark application was filed for ETHICA with the United States Patent and Trademark Office. The USPTO has given the ETHICA trademark a serial number of 78277322. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, February 23, 2017. This trademark is owned by Ethica Clinical Research Inc.. The ETHICA trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Study specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings

Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study ...

Research services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical ...
ethica

General Information


Serial Number78277322
Word MarkETHICA
Filing DateTuesday, July 22, 2003
Status800 - REGISTERED AND RENEWED
Status DateThursday, February 23, 2017
Registration Number3188634
Registration DateTuesday, December 26, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 10, 2006

Trademark Statements


Goods and ServicesStudy specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings
Goods and ServicesClinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants
Goods and ServicesResearch services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscript; developing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 21, 2005
Primary Code035
First Use Anywhere DateSunday, September 1, 2002
First Use In Commerce DateSunday, September 1, 2002

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2006
Primary Code041
First Use Anywhere DateSunday, September 1, 2002
First Use In Commerce DateSunday, September 1, 2002

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 5, 2003
Primary Code042
First Use Anywhere DateSunday, September 1, 2002
First Use In Commerce DateSunday, September 1, 2002

Trademark Owner History


Party NameETHICA CRO INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressKIRKLAND, QUEBEC H9H 3C4
CA

Party NameEthica Clinical Research Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMontreal, Quebec H4S1Z6
CA

Party NameEthica Clinical Research Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDorval, Quebec H9P 2V4
CA

Party NameEthica Clinical Research Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDorval, Quebec H9P 2V4
CA

Trademark Events


Event DateEvent Description
Wednesday, September 20, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 23, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, February 23, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, February 23, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 23, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 22, 2016TEAS SECTION 8 & 9 RECEIVED
Saturday, December 26, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 16, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 15, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 15, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 20, 2012TEAS SECTION 8 & 15 RECEIVED
Monday, November 23, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 23, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 29, 2007EXPARTE APPEAL TERMINATED
Tuesday, December 26, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, October 10, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2006NOTICE OF PUBLICATION
Friday, August 18, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 11, 2006ASSIGNED TO LIE
Tuesday, August 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 13, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 15, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, May 15, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, February 15, 2006ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, February 15, 2006ACTION CONTINUING FINAL - COMPLETED
Wednesday, December 28, 2005EX PARTE APPEAL-INSTITUTED
Wednesday, December 28, 2005JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 22, 2005EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, December 21, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 13, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 13, 2005FINAL REFUSAL E-MAILED
Monday, June 13, 2005FINAL REFUSAL WRITTEN
Friday, May 20, 2005USE AMENDMENT ACCEPTED
Wednesday, May 18, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, April 29, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 29, 2005FAX RECEIVED
Monday, April 11, 2005INQUIRY TO SUSPENSION E-MAILED
Monday, April 11, 2005SUSPENSION INQUIRY WRITTEN
Thursday, March 10, 2005SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, September 9, 2004LETTER OF SUSPENSION E-MAILED
Thursday, September 9, 2004SUSPENSION LETTER WRITTEN
Thursday, August 12, 2004AMENDMENT FROM APPLICANT ENTERED
Friday, July 30, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 12, 2004ASSIGNED TO LIE
Monday, August 9, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, July 26, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 9, 2004ASSIGNED TO LIE
Friday, July 30, 2004PAPER RECEIVED
Tuesday, January 27, 2004NON-FINAL ACTION E-MAILED
Monday, January 12, 2004ASSIGNED TO EXAMINER
Wednesday, September 17, 2003AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, September 10, 2003USE AMENDMENT FILED
Wednesday, September 10, 2003TEAS AMENDMENT OF USE RECEIVED